Article

Aquaporins: Water channels that maintain ocular health

Aquaporins are the water channels, the body's plumbing system, that move water across the biological compartment and without which life would cease, according to Peter Agre, MD, of Johns Hopkins University, Baltimore, who delivered the second keynote address at the ARVO annual meeting.

May 2 - Fort Lauderdale, FL - Aquaporins are the water channels, the body's plumbing system, that move water across the biological compartment and without which life would cease, according to Peter Agre, MD, of Johns Hopkins University, Baltimore, who delivered the second keynote address at the ARVO annual meeting.

When Dr. Agre, the 2003 recipient of the Nobel Prize in chemistry, and colleagues discovered aquaporin-1, they suspected that bilayer diffusion was insufficient to carry out the work needed to maintain stability in the body; selective water channels must exist that at the same time allow movement of water but that block protons. Deficits in aquaporin-1 result in disease states, an extreme example of which is individuals with no detectable aquaporin in any tissue.

Aquaporin-1 is present in the lens epithelium, the corneal endothelium, non-pigmented epithelium (ciliary and iris), and the trabecular meshwork. Other members of the aquaporin family have also been identified-aquaporin-3 (conjunctiva), aquaporin-4 (perivascular membranes in glial cells, Muller cells), and aquaporin-5 (apical membrane), he explained.

"We don't know what the overall significance of the protein is in eye tissues," Dr Agre said. "Preliminary evaluation of our human aquaporin-1 failed to identify any profound phenotype in the eye tissue. I suspect that the protein is important in stress states after corneal injuries, for example, the ability to maintain corneal transparency. We know where the protein is, we know its structure, but we don't know what it is. There is still a lot of work to be done on aquaporin in the eye."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.